These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23609402)

  • 1. Genetic variation and the risk of haloperidol-related parkinsonism in elderly patients: a candidate gene approach.
    Knol W; van Marum RJ; Jansen PA; Strengman E; Al Hadithy AF; Wilffert B; Schobben AF; Ophoff RA; Egberts TC
    J Clin Psychopharmacol; 2013 Jun; 33(3):405-10. PubMed ID: 23609402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonism in elderly users of haloperidol: associated with dose, plasma concentration, and duration of use.
    Knol W; van Marum RJ; Jansen PA; Egberts TC; Schobben AF
    J Clin Psychopharmacol; 2012 Oct; 32(5):688-93. PubMed ID: 22926605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of parkinsonism, rigidity, rest tremor, and bradykinesia in African-Caribbean inpatients: differences in association with dopamine and serotonin receptors.
    Al Hadithy AF; Wilffert B; Stewart RE; Looman NM; Bruggeman R; Brouwers JR; Matroos GE; van Os J; Hoek HW; van Harten PN
    Am J Med Genet B Neuropsychiatr Genet; 2008 Sep; 147B(6):890-7. PubMed ID: 18389501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life of elderly patients with antipsychotic-induced parkinsonism: a cross-sectional study.
    Schouten HJ; Knol W; Egberts TC; Schobben AF; Jansen PA; van Marum RJ
    J Am Med Dir Assoc; 2012 Jan; 13(1):82.e1-5. PubMed ID: 21450229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
    Gunes A; Scordo MG; Jaanson P; Dahl ML
    Psychopharmacology (Berl); 2007 Mar; 190(4):479-84. PubMed ID: 17102980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tardive dyskinesia and DRD3, HTR2A and HTR2C gene polymorphisms in Russian psychiatric inpatients from Siberia.
    Al Hadithy AF; Ivanova SA; Pechlivanoglou P; Semke A; Fedorenko O; Kornetova E; Ryadovaya L; Brouwers JR; Wilffert B; Bruggeman R; Loonen AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Apr; 33(3):475-81. PubMed ID: 19439249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
    J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between HTR2C polymorphisms and obesity in psychiatric patients using antipsychotics: a cross-sectional study.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Egberts AC; Scheffer H
    Pharmacogenomics J; 2007 Oct; 7(5):318-24. PubMed ID: 17016522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
    J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of dopamine D3, 5-HT2A and 5-HT2C receptor variants as pharmacogenetic determinants in tardive dyskinesia in African-Caribbean patients under chronic antipsychotic treatment: Curacao extrapyramidal syndromes study IX.
    Wilffert B; Al Hadithy AF; Sing VJ; Matroos G; Hoek HW; van Os J; Bruggeman R; Brouwers JR; van Harten PN
    J Psychopharmacol; 2009 Aug; 23(6):652-9. PubMed ID: 18562401
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Grubor M; Zivkovic M; Sagud M; Nikolac Perkovic M; Mihaljevic-Peles A; Pivac N; Muck-Seler D; Svob Strac D
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32231051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic predictors of antipsychotic-induced weight gain: a case-matched multi-gene study.
    Wu R; Zhao J; Shao P; Ou J; Chang M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 36(8):720-3. PubMed ID: 21937795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study.
    Risselada AJ; Vehof J; Bruggeman R; Wilffert B; Cohen D; Al Hadithy AF; Arends J; Mulder H
    Pharmacogenomics J; 2012 Feb; 12(1):62-7. PubMed ID: 20680028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia: a replication study.
    Mulder H; Cohen D; Scheffer H; Gispen-de Wied C; Arends J; Wilmink FW; Franke B; Egberts AC
    J Clin Psychopharmacol; 2009 Feb; 29(1):16-20. PubMed ID: 19142101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis.
    De Luca V; Müller DJ; Hwang R; Lieberman JA; Volavka J; Meltzer HY; Kennedy JL
    Hum Psychopharmacol; 2007 Oct; 22(7):463-7. PubMed ID: 17702092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
    Gunes A; Melkersson KI; Scordo MG; Dahl ML
    J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further evidence for the association between 5-HT2C receptor gene polymorphisms and extrapyramidal side effects in male schizophrenic patients.
    Gunes A; Dahl ML; Spina E; Scordo MG
    Eur J Clin Pharmacol; 2008 May; 64(5):477-82. PubMed ID: 18205001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphism of dopamine D2 receptor (TaqIA, TaqIB, and-141C Ins/Del) and dopamine degradation enzyme (COMT G158A, A-278G) genes and extrapyramidal symptoms in patients with schizophrenia and bipolar disorders.
    Lafuente A; Bernardo M; Mas S; Crescenti A; Aparici M; Gasso P; Deulofeu R; Mane A; Catalan R; Carne X
    Psychiatry Res; 2008 Nov; 161(2):131-41. PubMed ID: 18922583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.